Timely and Correct Transposition of Pharmacovigilance across Member States

  • Kaeding M
  • Schmälter J
  • Klika C
N/ACitations
Citations of this article
3Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

There has long been a vague supposition that the European Union (EU) has a transposition problem (Groenleer et al. 2010; Kaeding 2006, 2007a, b, 2008a, b, c, 2012; Kaeding and Versluis 2014; Klika 2015a, 2015b; Mastenbroek and Kaeding 2006, 2007; Schmälter 2017; Steunenberg et al. 2006; Steunenberg and Kaeding 2009). This chapter offers a first assessment of the timeliness of national transposition processes for all EU Member States and their respective national pharmacovigilance systems.

Cite

CITATION STYLE

APA

Kaeding, M., Schmälter, J., & Klika, C. (2017). Timely and Correct Transposition of Pharmacovigilance across Member States. In Pharmacovigilance in the European Union (pp. 35–43). Springer Fachmedien Wiesbaden. https://doi.org/10.1007/978-3-658-17276-3_4

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free